Communiqués Sio Gene Therapies Börse Stuttgart

Actions

6YY

US8293991043

Temps Différé Börse Stuttgart Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		-1,65%	-16,01%

2023	Sio Gene Therapies Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 31 décembre 2022	CI
2022	Le conseil d'administration de Sio Gene Therapies approuve le plan de liquidation et de dissolution ; les actions augmentent après les heures d'ouverture.	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	02/02	GL
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share	02/02	AQ
SIO GENE THERAPIES INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	06/04/23	AQ
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	15/03/23	PU
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	15/03/23	AQ
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	14/02/23	AQ
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/02/23	AQ
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution	14/12/22	GL
Sio Gene Therapies : Announces Board Approval of Plan of Complete Liquidation and Dissolution - Form 8-K	14/12/22	PU
SIO GENE THERAPIES INC. : Other Events, Financial Statements and Exhibits (form 8-K)	14/12/22	AQ
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/11/22	AQ
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/22	AQ
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results	10/11/22	AQ
Sio Gene Therapies : Failure to Satisfy Listing Rule - Form 8-K	14/09/22	PU
SIO GENE THERAPIES INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	14/09/22	AQ
Sio Gene Therapies : Announces Fiscal First Quarter 2022 Financial Results - Form 8-K	11/08/22	PU
SIO GENE THERAPIES INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	11/08/22	AQ
SIO GENE THERAPIES INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	11/08/22	AQ
Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results	11/08/22	AQ
Sio Gene Therapies : Announces Fiscal Year 2021 Year-End Financial Results - Form 8-K	14/06/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Sio Gene Therapies Börse Stuttgart

Actions

6YY

US8293991043

Communiqués

Filtres